C-reactive protein plasma levels but not factor VII activity predict clinical outcome in patients undergoing elective coronary intervention

被引:9
|
作者
Grander, W
Dichtl, W
Prokop, W
Roithinger, FX
Moes, N
Friedrich, G
Weidinger, F
Pachinger, O
机构
[1] Leopold Franzens Univ, Univ Hosp, Dept Internal Med, Div Cardiol, Innsbruck, Austria
[2] Leopold Franzens Univ, Univ Hosp, Cent Lab, Innsbruck, Austria
关键词
restenosis; stable angina; percutaneous coronary intervention; C-reactive protein; factor VII activity;
D O I
10.1002/clc.4960270407
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Both vascular inflammation as determined by C-reactive protein (CRP) and extrinsic coagulation as measured by factor VII activity (F VII) may predict clinical restenosis rate in patients with stable angina pectoris undergoing elective percutaneous coronary intervention (PCI). Hypothesis: The primary objective of this study was to investigate the associations between baseline CRP levels, F VII activity, and restenosis rate after elective PCI in a 6-month follow-up period. Methods: This prospective study included 81 patients aged greater than or equal to19 years undergoing PCI for angiographically significant (greater than or equal to70%) stenosis, with or without stenting, and 49 controls. Factor VII activity and CRP were measured in samples collected at angiography and 16-24 h post procedure after overnight fast. Successful PCI was defined as final diameter of <50% with TIMI3 flow and no complication within 1 h. After 6 months all patients who had undergone PCI were evaluated via a standardized questionnaire. Clinical restenosis was defined as the occurrence of a major adverse coronary events (MACE), within the follow-up period. Results: Diagnostic angiography led to a significant increase in CRP levels after 16-20 h in patients with discrete CAD (n = 22) but not in patients without any signs of coronary atherosclerosis (n = 27). During a 6-month follow-up after PCI, 17 of 81 (21%) patients developed MACE. Tertiles of CRP levels independently predicted clinical restenosis, as it developed in 33.3% of patients with the highest CRP levels (0.7-4.8 mg/dl), in 16.6% of patients with second tertile CRP levels (0.23-0.69 mg/dl), and in 7.4% of patients with lowest tertile CRP levels (0.0-0.22 mg/dl). There was a significant difference in the restenosis rate between patients from the first and the third tertiles (p = 0.018). Successful PCI was associated with a significant decrease of mean CRP levels after 6 months, whereas PCI in patients suffering from MACE led to no change in CRP levels. There was no association between factor VII activity and clinical outcome after PCI, and F VII activity did not change over a 6-month period. Conclusions: In patients with stable angina pectoris undergoing elective PCI, increased preprocedural and 6-month follow-up CRP plasma levels are associated with clinical restenosis. Factor VII plasma activity lacks such correlations.
引用
收藏
页码:211 / 216
页数:6
相关论文
共 50 条
  • [41] Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting
    Segev, A
    Kassam, S
    Buller, CE
    Lau, HK
    Sparkes, JD
    Connelly, PW
    Seidelin, PH
    Natarajan, MK
    Cohen, EA
    Strauss, BH
    EUROPEAN HEART JOURNAL, 2004, 25 (12) : 1029 - 1035
  • [42] Increased plasma levels of C-reactive protein in SARS patients.
    Chang, HL
    Chen, KT
    Lai, SK
    Kuo, HW
    Sul, IJ
    Sung, FC
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (11) : S39 - S39
  • [43] Simvastatin lowers plasma levels of C-reactive protein in hyperlipidemic patients
    Isaacsohn, J
    Davidson, MH
    Hunninghake, D
    Schrott, H
    Stein, EA
    Mitchel, YB
    Mercuri, M
    Stepanavage, ME
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 301A - 301A
  • [44] Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing Percutaneous Coronary Intervention
    Ricottini, E.
    Patti, G.
    Mangiacapra, F.
    Cannata, A.
    Cavallari, I.
    Vizzi, V.
    D'Ambrosio, A.
    Mega, S.
    Dicuonzo, G.
    Di Sciascio, G.
    EUROPEAN HEART JOURNAL, 2012, 33 : 305 - 305
  • [45] Elevated levels of admission C-reactive protein are not a marker of extensive coronary artery disease in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction
    Suleiman, M
    Gruberg, L
    Kerner, A
    Aronson, D
    Boulus, M
    Markiewicz, W
    Beyar, R
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 109L - 110L
  • [46] C-reactive protein levels and heart transplant outcome
    Labarrere, Carlos Alberto
    Campana, Gonzalo
    Boguslawski, George
    Ortiz, Miguel A.
    Sosa, Marcelo J.
    Terry, Colin
    Pitts, Douglas E.
    O'Donnell, Jacqueline A.
    Hormuth, David A.
    FASEB JOURNAL, 2007, 21 (05): : A185 - A185
  • [47] C-reactive protein levels correlate with functional outcome
    Munro, R
    Capell, H
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (09) : 1852 - 1852
  • [48] Prognostic value of preprocedural serum levels of C-reactive protein in patients with stable angina undergoing coronary stenting
    Dibra, A
    Kastrati, A
    Mehilli, J
    Braun, S
    Schühlen, H
    Hausleiter, J
    von Beckerath, N
    Markwardt, C
    Pinieck, S
    Schömig, A
    CIRCULATION, 2002, 106 (19) : 588 - 588
  • [49] Higher C-Reactive Protein Levels Predict Postoperative Delirium in Older Patients Undergoing Major Elective Surgery: A Longitudinal Nested Case-Control Study
    Dillon, Simon T.
    Vasunilashorn, Sarinnapha M.
    Ngo, Long
    Otu, Hasan H.
    Inouye, Sharon K.
    Jones, Richard N.
    Alsop, David C.
    Kuchel, George A.
    Metzger, Eran D.
    Arnold, Steven E.
    Marcantonio, Edward R.
    Libermann, Towia A.
    BIOLOGICAL PSYCHIATRY, 2017, 81 (02) : 145 - 153
  • [50] Does C-reactive protein predict outcomes of patients with stable angina and acute coronary syndrome who are undergoing percutaneous coronary intervention with drug-eluting stents?
    Wolfram, RM
    Buch, AN
    Xue, ZY
    Pichard, AD
    Suddath, W
    Satler, L
    Kent, KM
    Waksman, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 9B - 9B